Novasep Holding S.A.S. (“Novasep”) has today commenced an offer to purchase (the “Notes Offer”) any and all of its outstanding euro-denominated unsecured exchange notes due 2022 (the “Notes”).
Une alliance inédite au service de la filière de Bioproduction française
The collaboration covers the design, engineering and commissioning of a complete process line to produce High Purity Rare Sugars such as Tagatose and Allulose.
Expanded global capacity addresses growing demand for cell and gene therapy
• A disposal aligned with Novasep’s core strategy
• An opportunity for Novasep’s chromatography equipment division to accelerate its growth by joining an established leader in the sector
An ambitious goal to develop the skills necessary for health independence
Novasep announces a €6.5 million investment to upgrade an API manufacturing workshop at its Chasse-sur-Rhône site (69 - France)
Novasep, a leading supplier of services and technologies for the life sciences industry, announces Frontier Biotechnologies Inc. (“Frontier Biotech”) chooses Novasep Prochrom® HPLC chromatography columns and skids for its Nanjing (China) site.
In response to the rapidly developing Covid-19 epidemic, governments around the world are strengthening preventive and precautionary measures to limit the spread of the virus and protect populations.
A fire broke out this morning around 4:20 am outside of a small production workshop at our site in Chasse-sur-Rhône.